60 related articles for article (PubMed ID: 21214407)
41. Precursor T-Lymphoblastic Lymphoma Associated with t(8;9)(p11.2;q33): A Case Report and Review of the Literature.
Lv H; Hu S; Lu J; Zhai Q; Zhai Z; Du Z; Sun Y; Li J; He H; Wang Y
Acta Haematol; 2018; 139(3):176-182. PubMed ID: 29614500
[TBL] [Abstract][Full Text] [Related]
42. A further case of myeloproliferative syndrome with reciprocal translocation (8;13)(p11;q12).
Invernizzi R; Benatti C; Travaglino E; Girino M; Bernasconi P; Loni C; Ascari E
Haematologica; 2004 Feb; 89(2):239-41. PubMed ID: 15003903
[No Abstract] [Full Text] [Related]
43. Translocation t(3;8;9)(p25;p21;q34) in a patient with features of 8p11 myeloproliferative syndrome: a unique case and review of the literature.
Post GR; Holloman D; Christiansen L; Smith J; Stuart R; Lazarchick J
Leuk Res; 2010 Nov; 34(11):1543-4. PubMed ID: 20541805
[No Abstract] [Full Text] [Related]
44. Coexistent T-cell lymphoblastic lymphoma and an atypical myeloproliferative disorder associated with t(8;13)(p21;q14).
Somers GR; Slater H; Rockman S; Ekert H; Southey MC; Chow CW; Armes JE; Venter DJ
Pediatr Pathol Lab Med; 1997; 17(1):141-58. PubMed ID: 9050068
[TBL] [Abstract][Full Text] [Related]
45. [The 8p11 myeloproliferative syndrome: a review of recent literature].
Kirito K
Rinsho Ketsueki; 2019; 60(9):1157-1165. PubMed ID: 31597839
[TBL] [Abstract][Full Text] [Related]
46. Allogeneic hematopoietic stem cell transplantation for 8p11 myeloproliferative syndrome with BCR-FGFR1 gene rearrangement: a case report and literature review.
Konishi Y; Kondo T; Nakao K; Asagoe K; Otsuka Y; Nishikori M; Hishizawa M; Yamashita K; Takaori-Kondo A
Bone Marrow Transplant; 2019 Feb; 54(2):326-329. PubMed ID: 30087462
[No Abstract] [Full Text] [Related]
47. Pediatric 8p11 eosinophilic myeloproliferative syndrome (EMS): A case report and review of the literature.
Sarthy JF; Reddivalla N; Radhi M; Chastain K
Pediatr Blood Cancer; 2017 May; 64(5):. PubMed ID: 27808462
[TBL] [Abstract][Full Text] [Related]
48. Cytogenetic and molecular aspects of Philadelphia negative chronic myeloproliferative disorders: clinical implications.
Panani AD
Cancer Lett; 2007 Sep; 255(1):12-25. PubMed ID: 17383090
[TBL] [Abstract][Full Text] [Related]
49. [8p11 myeloproliferative syndrome cured by allogeneic hematopoietic stem cell transplantation: two case reports and literature review].
Xu LP; Chen Y; Shi HX; Huang XJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Dec; 45(6):993-6. PubMed ID: 24343089
[TBL] [Abstract][Full Text] [Related]
50. The 8p11 myeloproliferative syndrome: Genotypic and phenotypic classification and targeted therapy.
Li T; Zhang G; Zhang X; Lin H; Liu Q
Front Oncol; 2022; 12():1015792. PubMed ID: 36408177
[TBL] [Abstract][Full Text] [Related]
51. Molecular genetics and cytogenetics of myeloproliferative disorders.
Bench AJ; Nacheva EP; Champion KM; Green AR
Baillieres Clin Haematol; 1998 Dec; 11(4):819-48. PubMed ID: 10640219
[TBL] [Abstract][Full Text] [Related]
52. Translocation t(5;12)(q31-q33;p12-p13): a non-random translocation associated with a myeloid disorder with eosinophilia.
Baranger L; Szapiro N; Gardais J; Hillion J; Derre J; Francois S; Blanchet O; Boasson M; Berger R
Br J Haematol; 1994 Oct; 88(2):343-7. PubMed ID: 7803280
[TBL] [Abstract][Full Text] [Related]
53. Myeloproliferative disorder associated with 8p11 translocations.
Aguiar RC; Macdonald D; Mason PJ; Cross NC; Goldman JM
Blood; 1995 Jul; 86(2):834-5. PubMed ID: 7606017
[No Abstract] [Full Text] [Related]
54. [Myeloid/lymphoid neoplasms with eosinophilia and FGFR1 rearrangement: 5 cases report and literatures review].
Liu YT; Zhao JW; Feng J; Li QH; Chen YM; Qiu LG; Xiao ZJ; Li Y; Gong BF; Gong XY; Mi YC; Wang JX
Zhonghua Xue Ye Xue Za Zhi; 2019 Oct; 40(10):848-852. PubMed ID: 31775485
[No Abstract] [Full Text] [Related]
55. [Myeloproliferative neoplasm with FGFR1 rearrangement: a case report and literature review].
Chao H; Chen S; Zhang R; Zhou F; Zhou M
Zhonghua Xue Ye Xue Za Zhi; 2014 Oct; 35(10):951-3. PubMed ID: 25339338
[No Abstract] [Full Text] [Related]
56. Myeloproliferative disorders with t(8;9)(p12;q33): a case report and review of the literature.
Hu S; He Y; Zhu X; Li J; He H
Pediatr Hematol Oncol; 2011 Mar; 28(2):140-6. PubMed ID: 21214407
[TBL] [Abstract][Full Text] [Related]
57. Common features of myeloproliferative disorders with t(8;9)(p12;q33) and CEP110-FGFR1 fusion: report of a new case and review of the literature.
Mozziconacci MJ; Carbuccia N; Prebet T; Charbonnier A; Murati A; Vey N; Chaffanet M; Birnbaum D
Leuk Res; 2008 Aug; 32(8):1304-8. PubMed ID: 18096225
[TBL] [Abstract][Full Text] [Related]
58. 8p11 myeloproliferative syndrome: a review.
Jackson CC; Medeiros LJ; Miranda RN
Hum Pathol; 2010 Apr; 41(4):461-76. PubMed ID: 20226962
[TBL] [Abstract][Full Text] [Related]
59. A new myeloproliferative disorder associated with chromosomal translocations involving 8p11: a review.
Macdonald D; Aguiar RC; Mason PJ; Goldman JM; Cross NC
Leukemia; 1995 Oct; 9(10):1628-30. PubMed ID: 7564500
[TBL] [Abstract][Full Text] [Related]
60. The 8p11 myeloproliferative syndrome: a distinct clinical entity caused by constitutive activation of FGFR1.
Macdonald D; Reiter A; Cross NC
Acta Haematol; 2002; 107(2):101-7. PubMed ID: 11919391
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
